Atlas Trials

Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin

Clinical trial NCT00369954 · WITHDRAWN

Trial details

NCT number
NCT00369954
Sponsor
Gynecologic Oncology Group
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Start date
2006-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.